Detalhe da pesquisa
1.
Tbx20 controls the expression of the KCNH2 gene and of hERG channels.
Proc Natl Acad Sci U S A
; 114(3): E416-E425, 2017 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28049825
2.
Flecainide increases Kir2.1 currents by interacting with cysteine 311, decreasing the polyamine-induced rectification.
Proc Natl Acad Sci U S A
; 107(35): 15631-6, 2010 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-20713726
3.
Nitric oxide increases cardiac IK1 by nitrosylation of cysteine 76 of Kir2.1 channels.
Circ Res
; 105(4): 383-92, 2009 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-19608980
4.
Endocannabinoids and cannabinoid analogues block human cardiac Kv4.3 channels in a receptor-independent manner.
J Mol Cell Cardiol
; 48(1): 201-10, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19616555
5.
Pitx2c increases in atrial myocytes from chronic atrial fibrillation patients enhancing IKs and decreasing ICa,L.
Cardiovasc Res
; 109(3): 431-41, 2016 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26714926
6.
Nav1.5 N-terminal domain binding to α1-syntrophin increases membrane density of human Kir2.1, Kir2.2 and Nav1.5 channels.
Cardiovasc Res
; 110(2): 279-90, 2016 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26786162
7.
Regulation of SCN5A by microRNAs: miR-219 modulates SCN5A transcript expression and the effects of flecainide intoxication in mice.
Heart Rhythm
; 12(6): 1333-42, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25701775
8.
Structural basis of drugs that increase cardiac inward rectifier Kir2.1 currents.
Cardiovasc Res
; 104(2): 337-46, 2014 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25205296
9.
Chronic atrial fibrillation increases microRNA-21 in human atrial myocytes decreasing L-type calcium current.
Circ Arrhythm Electrophysiol
; 7(5): 861-8, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25107449
10.
Chronic atrial fibrillation up-regulates ß1-Adrenoceptors affecting repolarizing currents and action potential duration.
Cardiovasc Res
; 97(2): 379-88, 2013 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23060133
11.
p.D1690N Nav1.5 rescues p.G1748D mutation gating defects in a compound heterozygous Brugada syndrome patient.
Heart Rhythm
; 10(2): 264-72, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23085483
12.
Propafenone blocks human cardiac Kir2.x channels by decreasing the negative electrostatic charge in the cytoplasmic pore.
Biochem Pharmacol
; 86(2): 267-78, 2013 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23648307
13.
Functional characterization of a novel frameshift mutation in the C-terminus of the Nav1.5 channel underlying a Brugada syndrome with variable expression in a Spanish family.
PLoS One
; 8(11): e81493, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24363796
14.
Functional effects of a missense mutation in HERG associated with type 2 long QT syndrome.
Heart Rhythm
; 8(3): 463-70, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21109023
15.
Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner.
Cardiovasc Res
; 85(1): 56-67, 2010 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19689982
16.
In humans, chronic atrial fibrillation decreases the transient outward current and ultrarapid component of the delayed rectifier current differentially on each atria and increases the slow component of the delayed rectifier current in both.
J Am Coll Cardiol
; 55(21): 2346-54, 2010 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-20488306
17.
Investigational positive inotropic agents for acute heart failure.
Cardiovasc Hematol Disord Drug Targets
; 9(3): 193-205, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19534658
18.
Nitric oxide inhibits Kv4.3 and human cardiac transient outward potassium current (Ito1).
Cardiovasc Res
; 80(3): 375-84, 2008 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18678642